Sproxil

Sproxil

Sproxil is combating the global counterfeit drug ...

Other | United States of America |

 

Overview

Sproxil is combating the global counterfeit drug market through a Mobile Product Authentication™ (MPA™) solution that enables consumers to verify the authenticity of pharmaceutical products. Sproxil’s MPA solution allows customers to send a free text message containing a code found on a drug to Sproxil’s servers, which immediately respond and indicate whether the drug is genuine or fake. Sproxil has set up Africa’s first national mobile-based anti-counterfeit service in Nigeria, and Acumen Fund’s investment will enable the company to expand into Kenya and India.

Industry

Legal Structure

Operating Status

Employees

Other Operating

Funding and Financing Rounds


Team


Impact

Social Objectives:

Environmental Objectives:

Operational Impact:


Impact Reports & Metrics


Offices

US Headquarter


Boston, Massachusetts US



Explore

Revision History


Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Tags

COPYRIGHT 2017 IMPACTSPACE. ALL RIGHTS RESERVED.